Tristetraprolin Mediates Anti-inflammatory Effects of Nicotine in Lipopolysaccharide-stimulated Macrophages
Open Access
- 1 July 2011
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (28), 24735-24742
- https://doi.org/10.1074/jbc.m110.204859
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Stability of the LATS2 Tumor Suppressor Gene Is Regulated by TristetraprolinJournal of Biological Chemistry, 2010
- Tristetraprolin Is Required for Full Anti-Inflammatory Response of Murine Macrophages to IL-10The Journal of Immunology, 2009
- Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-κB phosphorylation and nuclear factor-κB transcriptional activity through nicotinic acetylcholine receptor α7Clinical and Experimental Immunology, 2006
- Control of dual‐specificity phosphatase‐1 expression in activated macrophages by IL‐10European Journal of Immunology, 2005
- MAPKAP Kinase 2 Phosphorylates Tristetraprolin on in Vivo Sites Including Ser178, a Site Required for 14-3-3 BindingJournal of Biological Chemistry, 2004
- Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammationNature, 2002
- Nicotine Inhibits the Production of Inflammatory Mediators in U937 Cells through Modulation of Nuclear Factor-kB ActivationBiochemical and Biophysical Research Communications, 1998
- A Pathogenetic Role for TNFα in the Syndrome of Cachexia, Arthritis, and Autoimmunity Resulting from Tristetraprolin (TTP) DeficiencyImmunity, 1996
- Dominant Negative Stat3 Mutant Inhibits Interleukin-6-induced Jak-STAT Signal TransductionJournal of Biological Chemistry, 1996
- Tumour necrosis factor is a compact trimerFEBS Letters, 1987